Does Metabolic Tumor Volume Predict Tumor Regression Grade After Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer?

Journal article

W Jin, E.A Mellon, S.E Hoffe, J.M Frakes, G.M Springett, B.A Centeno, R Kim, A Mahipal, J.M Pimiento, M.P Malafa, …

International journal of radiation oncology, biology, physics, Vol.96(2), pp.E195-E195

2016-10-01

Metrics

7 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Does Metabolic Tumor Volume Predict Tumor Regression Grade After Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer?
Creators: W Jin - University of South Florida
E.A Mellon - Moffitt Cancer Center
S.E Hoffe - Moffitt Cancer Center
J.M Frakes - Moffitt Cancer Center
G.M Springett - Moffitt Cancer Center
B.A Centeno - Moffitt Cancer Center
R Kim - Moffitt Cancer Center
A Mahipal - Moffitt Cancer Center
J.M Pimiento - Moffitt Cancer Center
M.P Malafa - Moffitt Cancer Center
K Latifi - Moffitt Cancer Center
Publication Details: International journal of radiation oncology, biology, physics, Vol.96(2), pp.E195-E195
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Radiation Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031713909902976